MediciNova Inc (4875)

Tokyo
Currency in JPY
233.0
+8.0(+3.56%)
Closed
4875 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
221.0233.0
52 wk Range
155.0354.0
Key Statistics
Edit
Bid/Ask
226.00 / 227.00
Prev. Close
233
Open
222
Day's Range
221-233
52 wk Range
155-354
Volume
77.2K
Average Vol. (3m)
107.31K
1-Year Change
8.37%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4875 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins
No news in this category
Looks like there are no results in this news category

MediciNova Inc Company Profile

MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2b/3 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction, as well as prevention of acute respiratory distress syndrome, and long COVID. It is also developing MN-001 (tipelukast), an orally bioavailable small molecule compound in Phase 2 clinical trial to treat fibrotic and other metabolic disorders, including nonalcoholic fatty liver disease and hypertriglycedemia. The company has a license agreement with Kyorin Pharmaceuticals for the development and commercialization of MN-166 and MN-001. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.

Compare 4875 to Peers and Sector

Metrics to compare
4875
Peers
Sector
Relationship
P/E Ratio
−6.8x−5.2x−0.5x
PEG Ratio
0.23−0.120.00
Price / Book
1.4x0.0x2.6x
Price / LTM Sales
-66.0x3.0x
Upside (Analyst Target)
-125.3%55.2%
Fair Value Upside
Unlock−0.4%9.7%Unlock

Earnings

Latest Release
Feb 20, 2025
EPS / Forecast
-9.06 / -8.39
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

90.96
PLTR
+4.09%
70.39
MRVL
-0.14%
67.94
NKE
-5.46%
248.71
TSLA
+5.27%
2.6800
SSKN
+0.75%

FAQ

What Is the MediciNova (4875) Stock Price Today?

The MediciNova stock price today is 233.00

What Stock Exchange Does MediciNova Trade On?

MediciNova is listed and trades on the Tokyo stock exchange.

What Is the Stock Symbol for MediciNova?

The stock symbol for MediciNova is "4875."

What Is the MediciNova Market Cap?

As of today, MediciNova market cap is 11.20B.

What is MediciNova Earnings Per Share?

The MediciNova EPS is -0.225.

What Is the Next MediciNova Earnings Date?

MediciNova will release its next earnings report on May 09, 2025.

From a Technical Analysis Perspective, Is 4875 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.